Swiss National Bank Has $5.52 Million Holdings in Itron, Inc. (NASDAQ:ITRI)

Swiss National Bank increased its holdings in shares of Itron, Inc. (NASDAQ:ITRI – Get Rating) by 1.9% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 108,900 shares of the scientific and technical instruments company’s stock after purchasing an additional 2,000 shares during the quarter. Swiss National Bank owned approximately 0.24% of Itron worth $5,516,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Quadrant Capital Group LLC grew its holdings in shares of Itron by 230.1% in the 3rd quarter. Quadrant Capital Group LLC now owns 845 shares of the scientific and technical instruments company’s stock valued at $36,000 after acquiring an additional 589 shares in the last quarter. Luken Investment Analytics LLC acquired a new position in shares of Itron during the 4th quarter worth approximately $46,000. US Bancorp DE raised its stake in shares of Itron by 30.7% during the 1st quarter. US Bancorp DE now owns 1,040 shares of the scientific and technical instruments company’s stock worth $54,000 after purchasing an additional 244 shares in the last quarter. Toroso Investments LLC boosted its holdings in shares of Itron by 31.8% in the 3rd quarter. Toroso Investments LLC now owns 1,776 shares of the scientific and technical instruments company’s stock valued at $75,000 after buying an additional 428 shares during the last quarter. Finally, FMR LLC grew its stake in shares of Itron by 73.0% in the second quarter. FMR LLC now owns 1,543 shares of the scientific and technical instruments company’s stock valued at $76,000 after buying an additional 651 shares in the last quarter. 96.64% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several analysts have issued reports on ITRI shares. Stephens reaffirmed an “equal weight” rating and set a $45.00 price target on shares of Itron in a research report on Tuesday, February 28th. StockNews.com initiated coverage on Itron in a report on Thursday. They set a “buy” rating for the company. Piper Sandler upped their price objective on Itron from $58.00 to $63.00 in a research note on Monday, May 8th. Robert W. Baird raised their price objective on Itron from $52.00 to $63.00 in a research report on Friday, May 5th. Finally, TheStreet raised shares of Itron from a “d+” rating to a “c-” rating in a research report on Thursday, March 2nd. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating, three have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $59.00.

Insider Activity

In other news, CEO Thomas Deitrich sold 1,516 shares of the firm’s stock in a transaction that occurred on Monday, February 27th. The shares were sold at an average price of $54.03, for a total transaction of $81,909.48. Following the completion of the sale, the chief executive officer now owns 172,780 shares of the company’s stock, valued at approximately $9,335,303.40. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. In other Itron news, CEO Thomas Deitrich sold 1,516 shares of the firm’s stock in a transaction on Monday, February 27th. The shares were sold at an average price of $54.03, for a total value of $81,909.48. Following the completion of the sale, the chief executive officer now directly owns 172,780 shares in the company, valued at $9,335,303.40. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Donald L. Reeves III sold 903 shares of Itron stock in a transaction on Wednesday, March 1st. The shares were sold at an average price of $55.52, for a total transaction of $50,134.56. Following the completion of the sale, the senior vice president now directly owns 10,820 shares of the company’s stock, valued at $600,726.40. The disclosure for this sale can be found here. In the last three months, insiders have sold 9,365 shares of company stock valued at $512,453. 1.47% of the stock is currently owned by insiders.

Itron Stock Performance

Shares of NASDAQ:ITRI opened at $68.02 on Friday. Itron, Inc. has a 1 year low of $39.38 and a 1 year high of $69.35. The stock has a market capitalization of $3.09 billion, a price-to-earnings ratio of -136.04 and a beta of 1.34. The company has a debt-to-equity ratio of 0.38, a current ratio of 1.68 and a quick ratio of 1.19. The company’s 50 day simple moving average is $55.96 and its 200 day simple moving average is $54.63.

Itron (NASDAQ:ITRI – Get Rating) last issued its quarterly earnings results on Thursday, May 4th. The scientific and technical instruments company reported $0.49 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.11 by $0.38. Itron had a positive return on equity of 5.88% and a negative net margin of 1.24%. The company had revenue of $494.62 million for the quarter, compared to analyst estimates of $464.26 million. During the same quarter last year, the company posted $0.11 EPS. The company’s revenue for the quarter was up 4.1% compared to the same quarter last year. As a group, research analysts predict that Itron, Inc. will post 1.34 EPS for the current fiscal year.

Itron Profile

(Get Rating)

Itron, Inc is a technology and services company, which engages in the provision of solutions that measure, manage, and analyze energy and water use. It operates through the following segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment includes hardware products used for measurement, control, or sensing that do not have communications capability embedded for use with its broader Itron systems.